Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › North Andover › NPI 1912106691
Physician

Malik, Faisal

Malik, Faisal was paid $75K by Medicaid between Nov 2021 and Feb 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.

33Billing provider infoMALIK, FAISAL
NORTH ANDOVER, MA 01845
33aNPI1912106691assigned 07/13/2007
28Total paid$75K
24GClaims1,057
24DCodes billed7
24AFirst – last monthNov 2021 – Feb 2024
Compared with peers

Next to other Internal Medicine Physician providers in Massachusetts

Rank by total paid#255 of 1,270
Median peer was paid$8K
This provider vs. median8.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2021200$14K
2022552$40K
2023278$19K
2024incomplete27$2K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 53% 368 339 $40K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 27% 237 237 $20K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 11% 260 250 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.9% 49 49 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.6% 49 49 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1.6% 82 82 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 12 12 $350.40

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.